The Swedish national registry for primary and secondary liver tumours, SweLiv, has now been in practice for 10 years, and a number of papers regarding gallbladder cancer, HCC and CRLM are now submitted and published from the registry. The registry has a coverage above 95%, and all liver resections with complications and postoperative mortality are included.